ORLANDO, Fla. -- Rod Pampling was named this week’s AstraZeneca Charity Challenge winner for his first-place standing entering the final round of the Bay Hill Invitational Presented by MasterCard. The AstraZeneca Charity Challenge, formerly known as the CRESTOR® Charity Challenge, is a season-long competition that recognizes and rewards the tournament leader entering the final round at 35 PGA TOUR events. Through the sponsorship, AstraZeneca will donate $3.5 million this year to designated health care charities and will have donated a three-year total of $9.7 million by the conclusion of the 2006 PGA TOUR season.

AstraZeneca produces a wide range of products that make significant contributions to treatment options and patient care including CRESTOR, NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year’s sponsorship, as part of its commitment to patient health and well being, AstraZeneca will also designate health care related charities across therapeutic areas as recipients at the 35 PGA TOUR events throughout the year.

For Pampling’s performance, AstraZeneca will donate $100,000 to Children's Digestive Health and Nutrition Foundation (CSHNF), on behalf of Pampling and the Bay Hill Invitational Presented by MasterCard. “We are extremely grateful and honored to be the recipient of this generous donation from the AstraZeneca Charity Challenge,” said William Balistreri, MD, President of CDHNF. “It has been our belief that the future of children’s digestive health is dependent on promoting new knowledge and clinical research. This support will provide for an unparalleled opportunity for CDHNF to encourage new and innovative research by funding research that has the potential to impact the children we care for in a major way.”

“AstraZeneca’s partnership with the PGA TOUR is an integral part of our mission of giving back in local communities throughout America,” said Tony Zook, CEO, AstraZeneca U.S. “The AstraZeneca Charity Challenge offers a unique platform for providing important disease awareness, health information and education to make a difference in the lives of patients and consumers everyday.”

The AstraZeneca Charity Challenge is the centerpiece of a multi-year PGA TOUR partnership with AstraZeneca (NYSE:AZN). Last year, AstraZeneca donated $3.5 million through the program. Highlights from the AZCC include:
•Last week the AstraZeneca Charity Challenge co-winners at The Honda Classic were Luke Donald and Billy Mayfair
•At eight (8) of the first nine (9) tournaments of 2006, the AstraZeneca Charity Challenge winner or co-winner went on to win the tournament
• More than 85 charities have benefited from the program
• Vijay Singh leads all players with eight AstraZeneca Charity Challenge wins. With some of his charitable “winnings,” Singh donated money to the American Red Cross Hurricane Relief Funds in Florida and New Orleans
•Other multiple winners have included Tom Lehman (four), Chad Campbell, Luke Donald, Sergio Garcia, Phil Mickelson and David Toms (three), and the following players who triumphed twice: Stuart Appleby, Bart Bryant, Chris DiMarco, Jim Furyk, Arron Oberholser, Joe Ogilvie, Rod Pampling, Kenny Perry, Carl Petterson, Ted Purdy, Adam Scott and Tiger Woods.

Fans can log on to www.astrazeneca.pgatour.com to read about past AstraZeneca Charity Challenge winners and learn more about AstraZeneca.

Children's Digestive Health and Nutrition Foundation (CSHNF)

The Children’s Digestive Health and Nutrition Foundation (CDHNF) is the leading source of information on pediatric gastrointestinal, liver and nutritional issues. CDHNF is dedicated to improving the care of infants, children and adolescents with digestive disorders by promoting advances in clinical care, research and education. More information on CDHNF can be found on www.cdhnf.org. CDHNF was established in 1998 by The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), is the leading society in the field of pediatric gastroenterology, hepatology and nutrition. More information on NASPGHAN can be found on www.naspghan.org.

About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world’s leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. Worldwide, AstraZeneca has six major research and development sites, four discovery facilities and a clinical research site. In total, AstraZeneca’s R&D organization is comprised of more 11,500 people located in seven countries including Canada, France, India, Japan, Sweden, United Kingdom and the United States.